Oxford Biomedica plc OXB.L Stock
Oxford Biomedica plc Price Chart
Oxford Biomedica plc OXB.L Financial and Trading Overview
| Oxford Biomedica plc stock price | 202.5 GBP |
| Previous Close | 468 GBP |
| Open | 466 GBP |
| Bid | 470 GBP x 0 |
| Ask | 473 GBP x 0 |
| Day's Range | 466 - 473 GBP |
| 52 Week Range | 276.62 - 575 GBP |
| Volume | 13.21K GBP |
| Avg. Volume | 131.79K GBP |
| Market Cap | 456.55M GBP |
| Beta (5Y Monthly) | 0.922222 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.64 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 992.75 GBP |
OXB.L Valuation Measures
| Enterprise Value | 455.51M GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.14161676 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.2612941 |
| Price/Book (mrq) | 222.48355 |
| Enterprise Value/Revenue | 3.254 |
| Enterprise Value/EBITDA | -18.198 |
Trading Information
Oxford Biomedica plc Stock Price History
| Beta (5Y Monthly) | 0.922222 |
| 52-Week Change | 12.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 575 GBP |
| 52 Week Low | 276.62 GBP |
| 50-Day Moving Average | 435.97 GBP |
| 200-Day Moving Average | 419.22 GBP |
OXB.L Share Statistics
| Avg. Volume (3 month) | 131.79K GBP |
| Avg. Daily Volume (10-Days) | 214.56K GBP |
| Shares Outstanding | 96.52M |
| Float | 69.74M |
| Short Ratio | N/A |
| % Held by Insiders | 8.56% |
| % Held by Institutions | 61.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -27.97% |
| Operating Margin (ttm) | -33.18% |
| Gross Margin | 49.41% |
| EBITDA Margin | -17.88% |
Management Effectiveness
| Return on Assets (ttm) | -8.32% |
| Return on Equity (ttm) | -21.32% |
Income Statement
| Revenue (ttm) | 139.99M GBP |
| Revenue Per Share (ttm) | 1.48 GBP |
| Quarterly Revenue Growth (yoy) | 23.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -25031000 GBP |
| Net Income Avi to Common (ttm) | -39157000 GBP |
| Diluted EPS (ttm) | -0.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 141.31M GBP |
| Total Cash Per Share (mrq) | 1.47 GBP |
| Total Debt (mrq) | 114.28M GBP |
| Total Debt/Equity (mrq) | 48.39 GBP |
| Current Ratio (mrq) | 3.612 |
| Book Value Per Share (mrq) | 2.126 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12615000 GBP |
| Levered Free Cash Flow (ttm) | -12800250 GBP |
Profile of Oxford Biomedica plc
| Country | United Kingdom |
| State | N/A |
| City | Oxford |
| Address | Windrush Court |
| ZIP | OX4 6LT |
| Phone | 44 1865 783 000 |
| Website | https://www.oxb.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 894 |
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products include Axo-Lenti-PD, a gene-based treatment for parkinson's disease; OXB-302, which is in pre-clinical stage for the treatment of haematological malignancies and tumours; and OXB-401 that is in pre-clinical stage for the treatment of liver indication; as well as OXB-40X, OXB-40Y, and OXB-40Z, which are in pre-clinical stage for liver indication. The company has collaborations with Boehringer Ingelheim, Immatics, Arcellx, Orchard, and Beam Therapeutics; an agreement with Homology Medicines; license and clinical supply agreement with Juno Therapeutics, Inc.; and master services and development agreement with AstraZeneca UK Ltd and Serum Life Sciences Ltd. The company also has a strategic collaboration with Kite Pharma to develop and commercialize CART-ddBCMA, a lead late-stage product candidate. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.
Q&A For Oxford Biomedica plc Stock
What is a current OXB.L stock price?
Oxford Biomedica plc OXB.L stock price today per share is 202.5 GBP.
How to purchase Oxford Biomedica plc stock?
You can buy OXB.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oxford Biomedica plc?
The stock symbol or ticker of Oxford Biomedica plc is OXB.L.
Which industry does the Oxford Biomedica plc company belong to?
The Oxford Biomedica plc industry is Biotechnology.
How many shares does Oxford Biomedica plc have in circulation?
The max supply of Oxford Biomedica plc shares is 1M.
What is Oxford Biomedica plc Price to Earnings Ratio (PE Ratio)?
Oxford Biomedica plc PE Ratio is now.
What was Oxford Biomedica plc earnings per share over the trailing 12 months (TTM)?
Oxford Biomedica plc EPS is -0.64 GBP over the trailing 12 months.
Which sector does the Oxford Biomedica plc company belong to?
The Oxford Biomedica plc sector is Healthcare.
Oxford Biomedica plc OXB.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| UK FTSE All Share FTAS | 4353.66 GBP 5568.05 USD |
+0.72
|
— — | 4322.37 GBP 5528.03 USD | 4382.9 GBP 5605.45 USD | — - | — — |
- {{ link.label }} {{link}}